Filter Results
:
(1,106)
Show Results For
-
All HBS Web
(1,106)
- People (1)
- News (308)
- Research (683)
- Events (5)
- Multimedia (15)
- Faculty Publications (399)
Show Results For
-
All HBS Web
(1,106)
- People (1)
- News (308)
- Research (683)
- Events (5)
- Multimedia (15)
- Faculty Publications (399)
- 11 Mar 2008
- Working Paper Summaries
Finding Missing Markets (and a disturbing epilogue): Evidence from an Export Crop Adoption and Marketing Intervention in Kenya
- 25 Feb 2020
- News
Alumni and Faculty Books for March 2020
impact of changes to an experience or product. Once an esoteric tool for academic research, the randomized controlled trial has gone mainstream—and is becoming an important part of the managerial toolkit. In The Power of Experiments:...
View Details
- 28 May 2019
- News
Alumni and Faculty Books for June 2019
transformation. Through trial and error, observation and interpretation, the new managers learned what it took to become effective business leaders. The Business of Platforms...
View Details
- 01 Mar 2016
- News
Alumni and Faculty Books for March 2016
Dressler (AMP 67, 1973) (Dudley Court Press) Dressler has written a love story and a travel book, filled with stories and photos of wild animals, diplomatic soirées, cultural...
View Details
- June 2002
- Background Note
Note on the Value of Life
By: Michael A. Wheeler and Carlos Gonzalez
This case summarizes how American courts measure damages in wrongful death suits. Various standards are compared, as are their implications for business management.
View Details
Keywords:
Judgments;
Courts and Trials;
Business or Company Management;
Standards;
Negotiation;
United States
Wheeler, Michael A., and Carlos Gonzalez. "Note on the Value of Life." Harvard Business School Background Note 902-152, June 2002.
- October 2013
- Case
FasterCures: Removing Barriers to Treatments
By: Richard G. Hamermesh and James Weber
In mid-2013, as FasterCures celebrated its 10th anniversary as a center of the Milken Institute, Executive Director Margaret Anderson thought about what the organization should do to ensure it had even more impact in its next 10 years. FasterCures was a non-profit... View Details
Keywords:
Health Care;
Health Care Industry;
Health Care Policy;
Health Services;
Healthcare;
Healthcare Reform;
Healthcare Ventures;
Nonprofit;
Non-profit Management;
Not-for-profit;
Incubator;
Accelerator;
Venture Philanthropy;
Medical Services;
Medical Solutions;
Medical Research;
Medical Treatment;
Clinical Trials;
Drug Reimbursement;
Early Stage;
Early Stage Research Funding;
Early Stage Funding;
Milken Institute;
Michael Milken;
David Baltimore;
Partnering For Cures;
National Institutes Of Health;
Cancer Care In The U.S.;
Cancer Care Services;
Policy-making;
Health Care and Treatment;
Health;
Health Testing and Trials;
Entrepreneurship;
Social Entrepreneurship;
Nonprofit Organizations;
Policy;
Health Industry;
United States;
District of Columbia
Hamermesh, Richard G., and James Weber. "FasterCures: Removing Barriers to Treatments." Harvard Business School Case 814-003, October 2013.
- 28 Mar 2023
- Research & Ideas
The FDA’s Speedy Drug Approvals Are Safe: A Win-Win for Patients and Pharma Innovation
spent $83 billion on research and development (R&D) in 2019, according to a 2021 report from the nonpartisan Congressional Budget Office (CBO). The median cost to develop one drug was $900 million, with half of that amount going...
View Details
- 15 Oct 2001
- Research & Ideas
Four Questions for David Garvin and Michael Roberto
effective approach to decision making. It does, after all, work exceedingly well in our court system, where both sides are represented by skilled attorneys, discovery proceedings unearth common information View Details
Keywords:
by Martha Lagace
- Web
Teaching Cases - Institute For Strategy And Competitiveness
2008, patients seeking a hip or knee replacement in Stockholm County faced wait times of up to two years of sometimes debilitating pain, intermittent missed work and income, and the View Details
- February 2020
- Teaching Note
Theranos: Who Has Blood on Their Hands? (A) and (B)
By: Nien-he Hsieh and Christina R. Wing
Teaching Note for HBS Nos. 619-039 and 320-091.
View Details
- August 2013
- Course Overview Note
Building Life Science Businesses Fall 2013: Course Outline and Syllabus
This Course Outline and Syllabus gives an overview of the Fall 2013 class Building Life Science Businesses.
View Details
Keywords:
Healthcare Ventures;
Entrepreneurial Management;
Entrepreneurship;
Entrepreneurs;
Health Care and Treatment;
Health Testing and Trials;
Medical Specialties;
Medical Devices and Supplies Industry;
Medical Devices and Supplies Industry;
Medical Devices and Supplies Industry;
Asia;
North America;
Europe
Hamermesh, Richard G. "Building Life Science Businesses Fall 2013: Course Outline and Syllabus." Harvard Business School Course Overview Note 814-019, August 2013.
- 03 Jun 2020
- Research & Ideas
Who Guarantees Your Workplace Is Safe for Return?
As we start to think about returning to work, shopping, and recreation, there is much talk about transformed workplaces and innovative social distancing designs. But how will companies, workers, View Details
- 11 Aug 2003
- Research & Ideas
Cheap, Fast, and In Control: How Tech Aids Innovation
Harvard Business School, discusses how businesses can sidestep the often prohibitive costs and time-consuming trials of experimentation by implementing new technologies. Wendy Guild: We've all heard the old...
View Details
Keywords:
by Wendy Guild
- September 2012 (Revised September 2012)
- Course Overview Note
Building Life Science Businesses Fall 2012: Course Outline and Syllabus
This Course Outline and Syllabus gives an overview of the Fall 2012 class Building Life Science Businesses
View Details
Keywords:
Healthcare Ventures;
Entrepreneurial Management;
Entrepreneurship;
Entrepreneurs;
Health Care and Treatment;
Health Testing and Trials;
Medical Specialties;
Medical Devices and Supplies Industry;
Medical Devices and Supplies Industry;
Medical Devices and Supplies Industry;
Asia;
North America;
Europe
- 01 Aug 2017
- First Look
First Look at New Research and Ideas, August 1
Abstract—Objective: Assess whether a commitment contract informed by behavioral economics leads to persistent virologic suppression among HIV-positive patients with poor antiretroviral therapy (ART) adherence. Design: Single-center pilot randomized clinical View Details
Keywords:
Sean Silverthorne
- 15 Dec 2008
- Research & Ideas
The Surprisingly Successful Marriages of Multinationals and Social Brands
appreciate the social value dimension of the mice's missions or failing to respect their distinctive operating culture can create incompatibility and conflict that will probably cancel the courting or sour...
View Details
- August 2012 (Revised March 2013)
- Case
Preem (A)
By: Bo Becker, Annelena Lobb and Aldo Sesia
High yield bond fund Proventus Capital Partners (PCP) has invested in underwater bonds issued by Preem, a large oil refinery. As maturity approaches, in the midst of financial crisis, Preem appear unlikely to be able to refinance. Meanwhile, Prreem has a complicated...
View Details
Keywords:
Insolvency and Bankruptcy;
Financial Liquidity;
Restructuring;
Courts and Trials;
Negotiation;
Bonds;
Mining Industry;
Energy Industry;
Europe
Becker, Bo, Annelena Lobb, and Aldo Sesia. "Preem (A)." Harvard Business School Case 213-008, August 2012. (Revised March 2013.)
- July 2014 (Revised January 2017)
- Course Overview Note
Building Life Science Businesses Spring Term 2017: Course Outline and Syllabus
This Course Outline and Syllabus gives an overview of the Spring 2016 class Building Life Science Businesses.7
View Details
Keywords:
Healthcare Ventures;
Entrepreneurial Management;
Entrepreneurship;
Entrepreneurs;
Health Care and Treatment;
Health Testing and Trials;
Medical Specialties;
Medical Devices and Supplies Industry;
Medical Devices and Supplies Industry;
Medical Devices and Supplies Industry;
Asia;
North America;
Europe
Hamermesh, Richard G. "Building Life Science Businesses Spring Term 2017: Course Outline and Syllabus." Harvard Business School Course Overview Note 815-003, July 2014. (Revised January 2017.)
- April 2009 (Revised March 2010)
- Background Note
Restructuring Distressed Companies -- Cross-National Comparisons
This note describes briefly bankruptcy regimes and out of court restructuring in 5 countries, the U.S., the U.K., Germany, France and Japan.
View Details
Keywords:
Restructuring;
Insolvency and Bankruptcy;
Cross-Cultural and Cross-Border Issues;
Laws and Statutes
Fruhan, William E. "Restructuring Distressed Companies -- Cross-National Comparisons." Harvard Business School Background Note 209-111, April 2009. (Revised March 2010.)